Title: CRISPR screening in the study of human disease

**Abstract**

Genome editing techniques have revolutionized the way that researchers study genes and their functions in eukaryotic systems and model species. Here we report the development of the whole genome CRISPR/Cas knockout library and its application in the identification of new drug targets through function-based screening and high-throughput sequencing analysis. Representative screenings will be presented, especially for the identification of host components important for *Clostridium difficile* infections and HCV infection. In addition, we have recently developed CRISPR/Cas9-mediated genomic deletion screening for long non-coding RNAs using paired-gRNAs, further expanding CRISPR toolbox for mammalian genetics. The application of these powerful genetic screening strategies will have broad application in the discovery of disease mechanisms and drug targets.

**References**

1\. Peng J, Zhou Y, Zhu S and Wei W. (2015) High-throughput Screens in Mammalian Cells Using the CRISPR-Cas9 System. *FEBS Journal,* DOI: 10.1111/febs.13251.

2\. Ren Q, Li C, Yuan P, Cai C, Luo G, Zhang L and Wei W. (2015) A Dual-Reporter System for Real-Time Monitoring and High-throughput CRISPR/Cas9 Library Screening of the Hepatitis C Virus. *Sci. Rep.* 5, 8865.

3\. Yuan P, Zhang H, Cai C, Zhu S, Zhou Y, Yang X, He R, Li C, Guo S, Li S, Huang T, Feng H and Wei W. (2015) Chondroitin sulfate proteoglycan 4 functions as the cellular receptor for *Clostridium difficile* toxin B. *Cell Res.* 25:157--168.

4\. Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y and Wei W. (2014) High-throughput Screening of a CRISPR/Cas Library for Functional Genomics in Human Cells. *Nature* 509(7501): 487--91.
